Miles Capital’s Lifecore Biomedical LFCR Stock Holding History

Miles Capital’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-24,389	Closed	-$289K	–	165
2015 Q4	$289K	Sell	24,389 -86	-0.4%	-$1.06K	0.2%	125
2015 Q3	$286K	Sell	24,475 -106	-0.4%	-$1.4K	0.21%	127
2015 Q2	$355K	Buy	+24,581	New	+$355K	0.23%	120

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Miles Capital's LFCR Position: Q1 2016 in Review

Miles Capital sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 24,389 shares — an estimated $289K sold.

Miles Capital first reported a position in LFCR in Q2 2015 and held it in 3 quarters. The position peaked at $355K in Q2 2015. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

Miles Capital reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
Miles Capital sold 24,389 Lifecore Biomedical shares in Q1 2016, an estimated $289K.
Miles Capital first reported a position in Lifecore Biomedical in Q2 2015 and held it in 3 quarters.
Miles Capital's Lifecore Biomedical position peaked at $355K in Q2 2015.
96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on Miles Capital's 13F filing for Q1 2016, filed 12 May 2016.